CareTalk: Healthcare. Unfiltered.
A Brief History of AI in Healthcare W/ Lekan Wang, Partner, JSL Health Capital
Why It Matters
Understanding AI’s rapid maturation helps clinicians, investors, and policymakers gauge realistic expectations for technology‑driven improvements in care delivery and drug development. As AI moves from hype to validated outcomes, the episode highlights timely opportunities—and cautions—for leveraging these tools to reduce costs, expand access, and accelerate cures in the U.S. healthcare system.
Key Takeaways
- •Palantir pioneered data integration for healthcare and epidemiology
- •Transformer architecture and massive compute sparked modern AI breakthroughs
- •AI can reduce documentation burden and improve patient access
- •JSL invests in AI-first healthcare firms with proprietary data
- •Debate persists on AI generalization versus “stochastic parrots”
Pulse Analysis
On CareTalk, Lekan Wang traces his journey from a genomics‑obsessed student to a Palantir engineer who first tackled healthcare data problems. At Palantir, he helped the CDC stitch together fragmented state‑level food‑borne outbreak reports, proving that integrating disparate datasets could yield actionable public‑health insights. He describes how early work relied on classic statistical models and large databases, but the emergence of machine‑learning loops gradually turned those tools into what we now call artificial intelligence. This historical lens shows why data integration remains the foundation for every AI breakthrough in medicine.
The current AI surge is powered by three forces: unprecedented data volumes, exploding compute power, and the transformer model introduced in the 2017 “Attention Is All You Need” paper. GPUs, TPUs and custom ASICs now train models on internet‑scale and synthetic datasets, while transformers enable scalable attention across billions of parameters. In healthcare, these advances promise to cut the massive documentation load that clinicians face, streamline patient triage, and close the access gap that leaves many Americans without timely care. Early clinical studies already show AI reducing avoidable medical errors and accelerating diagnostic pathways.
JSL Health Capital embodies this optimism by backing AI‑first companies that own or generate proprietary clinical data. Their portfolio includes Symphony, which uses generative chemistry models and robotic flow‑chemistry to design and synthesize drug candidates on demand, and General Medicine, which leverages AI to make care navigation transparent and to automate scheduling and triage. Wang stresses that the real value lies in models trained on rich, domain‑specific data rather than generic internet text, addressing the “stochastic parrot” criticism. While questions about true generalization remain, investors see a target‑rich environment—high administrative overhead, diagnostic delays, and preventable errors—where AI can deliver measurable improvements.
Episode Description
Send us Fan Mail
AI has been promising to transform healthcare for decades. So what's actually different this time? From Palantir's early data integration work to the frontier of AI-driven drug discovery, the evidence for optimism is growing and so is the urgency to get it right.
Lekan Wang, Partner, JSL Health Capital joins host John Driscoll to discuss the real history of AI, where it's already delivering results in healthcare, and what investors are betting on next.
🎙️⚕️ABOUT LEKAN WANG
Lekan Wang is a partner at JSL Health Capital, an AI first healthcare investment fund that is joining with some of the cutting edge companies that are leveraging technology in advancing healthcare and hopefully creating better outcomes at lower costs.
🎙️⚕️ABOUT CARETALK
CareTalk is a weekly podcast that provides an incisive, no B.S. view of the US healthcare industry. Join co-hosts John Driscoll (President U.S. Healthcare and EVP, Walgreens Boots Alliance) and David Williams (President, Health Business Group) as they debate the latest in US healthcare news, business and policy.
GET IN TOUCH
Follow CareTalk on LinkedIn
Become a CareTalk sponsor
Guest appearance requests
Visit us on the web
Subscribe to the CareTalk Newsletter
Support the show
⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.
Comments
Want to join the conversation?
Loading comments...